世界の小児神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pediatric Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4487
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、小児神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫療法、化学療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・小児神経芽細胞腫治療の市場動向
・企業の競争状況、市場シェア
・小児神経芽細胞腫治療の種類別市場規模（免疫療法、化学療法、その他）
・小児神経芽細胞腫治療の用途別市場規模（病院、診療所、その他）
・小児神経芽細胞腫治療の北米市場規模2016-2027（アメリカ、カナダ）
・小児神経芽細胞腫治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・小児神経芽細胞腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・小児神経芽細胞腫治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・小児神経芽細胞腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（United Therapeutics、Apeiron Biologics、Pfizer、Bayer、Baxter、Cellectar Biosciences、MacroGenics）
・結論

In terms of therapy type, the market has been classified into immunotherapy, chemotherapy, and others. The chemotherapy segment held leading market share in 2017.

Market Analysis and Insights: Global Pediatric Neuroblastoma Treatment Market
The global Pediatric Neuroblastoma Treatment market size is projected to reach US$ 825.8 million by 2026, from US$ 582.8 million in 2019, at a CAGR of 5.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pediatric Neuroblastoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pediatric Neuroblastoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pediatric Neuroblastoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pediatric Neuroblastoma Treatment market.

Global Pediatric Neuroblastoma Treatment Scope and Market Size
Pediatric Neuroblastoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pediatric Neuroblastoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunotherapy
Chemotherapy
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
United Therapeutics
Apeiron Biologics
Pfizer
Bayer
Baxter
Cellectar Biosciences
MacroGenics

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunotherapy
1.2.3 Chemotherapy
1.2.4 Others
1.3 Market by Application
1.3.1 Global Pediatric Neuroblastoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pediatric Neuroblastoma Treatment Market Perspective (2016-2027)
2.2 Pediatric Neuroblastoma Treatment Growth Trends by Regions
2.2.1 Pediatric Neuroblastoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pediatric Neuroblastoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Pediatric Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Pediatric Neuroblastoma Treatment Industry Dynamic
2.3.1 Pediatric Neuroblastoma Treatment Market Trends
2.3.2 Pediatric Neuroblastoma Treatment Market Drivers
2.3.3 Pediatric Neuroblastoma Treatment Market Challenges
2.3.4 Pediatric Neuroblastoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue
3.1.1 Global Top Pediatric Neuroblastoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Pediatric Neuroblastoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Pediatric Neuroblastoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pediatric Neuroblastoma Treatment Revenue
3.4 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio
3.4.1 Global Pediatric Neuroblastoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Neuroblastoma Treatment Revenue in 2020
3.5 Pediatric Neuroblastoma Treatment Key Players Head office and Area Served
3.6 Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
3.7 Date of Enter into Pediatric Neuroblastoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pediatric Neuroblastoma Treatment Breakdown Data by Type
4.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027)

5 Pediatric Neuroblastoma Treatment Breakdown Data by Application
5.1 Global Pediatric Neuroblastoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pediatric Neuroblastoma Treatment Market Size (2016-2027)
6.2 North America Pediatric Neuroblastoma Treatment Market Size by Type
6.2.1 North America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2027)
6.3 North America Pediatric Neuroblastoma Treatment Market Size by Application
6.3.1 North America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2027)
6.4 North America Pediatric Neuroblastoma Treatment Market Size by Country
6.4.1 North America Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Pediatric Neuroblastoma Treatment Market Size (2016-2027)
7.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type
7.2.1 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Pediatric Neuroblastoma Treatment Market Size by Type (2016-2027)
7.3 Europe Pediatric Neuroblastoma Treatment Market Size by Application
7.3.1 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Pediatric Neuroblastoma Treatment Market Size by Application (2016-2027)
7.4 Europe Pediatric Neuroblastoma Treatment Market Size by Country
7.4.1 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type
8.2.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application
8.3.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region
8.4.1 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pediatric Neuroblastoma Treatment Market Size (2016-2027)
9.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type
9.2.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Application
9.3.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Pediatric Neuroblastoma Treatment Market Size by Country
9.4.1 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type
10.2.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application
10.3.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country
10.4.1 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 United Therapeutics
11.1.1 United Therapeutics Company Details
11.1.2 United Therapeutics Business Overview
11.1.3 United Therapeutics Pediatric Neuroblastoma Treatment Introduction
11.1.4 United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.1.5 United Therapeutics Recent Development
11.2 Apeiron Biologics
11.2.1 Apeiron Biologics Company Details
11.2.2 Apeiron Biologics Business Overview
11.2.3 Apeiron Biologics Pediatric Neuroblastoma Treatment Introduction
11.2.4 Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.2.5 Apeiron Biologics Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Pediatric Neuroblastoma Treatment Introduction
11.3.4 Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Pediatric Neuroblastoma Treatment Introduction
11.4.4 Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.4.5 Bayer Recent Development
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Pediatric Neuroblastoma Treatment Introduction
11.5.4 Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.5.5 Baxter Recent Development
11.6 Cellectar Biosciences
11.6.1 Cellectar Biosciences Company Details
11.6.2 Cellectar Biosciences Business Overview
11.6.3 Cellectar Biosciences Pediatric Neuroblastoma Treatment Introduction
11.6.4 Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.6.5 Cellectar Biosciences Recent Development
11.7 MacroGenics
11.7.1 MacroGenics Company Details
11.7.2 MacroGenics Business Overview
11.7.3 MacroGenics Pediatric Neuroblastoma Treatment Introduction
11.7.4 MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021)
11.7.5 MacroGenics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pediatric Neuroblastoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunotherapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Others
Table 5. Global Pediatric Neuroblastoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pediatric Neuroblastoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Pediatric Neuroblastoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2016-2021)
Table 9. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2022-2027)
Table 11. Pediatric Neuroblastoma Treatment Market Trends
Table 12. Pediatric Neuroblastoma Treatment Market Drivers
Table 13. Pediatric Neuroblastoma Treatment Market Challenges
Table 14. Pediatric Neuroblastoma Treatment Market Restraints
Table 15. Global Pediatric Neuroblastoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Pediatric Neuroblastoma Treatment Market Share by Players (2016-2021)
Table 17. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2020)
Table 18. Ranking of Global Top Pediatric Neuroblastoma Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Pediatric Neuroblastoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pediatric Neuroblastoma Treatment Product Solution and Service
Table 22. Date of Enter into Pediatric Neuroblastoma Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Pediatric Neuroblastoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Pediatric Neuroblastoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. United Therapeutics Company Details
Table 63. United Therapeutics Business Overview
Table 64. United Therapeutics Pediatric Neuroblastoma Treatment Product
Table 65. United Therapeutics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 66. United Therapeutics Recent Development
Table 67. Apeiron Biologics Company Details
Table 68. Apeiron Biologics Business Overview
Table 69. Apeiron Biologics Pediatric Neuroblastoma Treatment Product
Table 70. Apeiron Biologics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 71. Apeiron Biologics Recent Development
Table 72. Pfizer Company Details
Table 73. Pfizer Business Overview
Table 74. Pfizer Pediatric Neuroblastoma Treatment Product
Table 75. Pfizer Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 76. Pfizer Recent Development
Table 77. Bayer Company Details
Table 78. Bayer Business Overview
Table 79. Bayer Pediatric Neuroblastoma Treatment Product
Table 80. Bayer Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 81. Bayer Recent Development
Table 82. Baxter Company Details
Table 83. Baxter Business Overview
Table 84. Baxter Pediatric Neuroblastoma Treatment Product
Table 85. Baxter Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 86. Baxter Recent Development
Table 87. Cellectar Biosciences Company Details
Table 88. Cellectar Biosciences Business Overview
Table 89. Cellectar Biosciences Pediatric Neuroblastoma Treatment Product
Table 90. Cellectar Biosciences Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 91. Cellectar Biosciences Recent Development
Table 92. MacroGenics Company Details
Table 93. MacroGenics Business Overview
Table 94. MacroGenics Pediatric Neuroblastoma Treatment Product
Table 95. MacroGenics Revenue in Pediatric Neuroblastoma Treatment Business (2016-2021) & (US$ Million)
Table 96. MacroGenics Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pediatric Neuroblastoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunotherapy Features
Figure 3. Chemotherapy Features
Figure 4. Others Features
Figure 5. Global Pediatric Neuroblastoma Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Pediatric Neuroblastoma Treatment Report Years Considered
Figure 10. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Pediatric Neuroblastoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Pediatric Neuroblastoma Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Pediatric Neuroblastoma Treatment Market Share by Regions (2022-2027)
Figure 14. Global Pediatric Neuroblastoma Treatment Market Share by Players in 2020
Figure 15. Global Top Pediatric Neuroblastoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Neuroblastoma Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Pediatric Neuroblastoma Treatment Revenue in 2020
Figure 17. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Pediatric Neuroblastoma Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Pediatric Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 21. North America Pediatric Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 22. North America Pediatric Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 23. United States Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Pediatric Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 27. Europe Pediatric Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 28. Europe Pediatric Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 29. Germany Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Pediatric Neuroblastoma Treatment Market Share by Region (2016-2027)
Figure 39. China Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Pediatric Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Pediatric Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Pediatric Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Pediatric Neuroblastoma Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Pediatric Neuroblastoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. United Therapeutics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 59. Apeiron Biologics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 60. Pfizer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 62. Baxter Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 63. Cellectar Biosciences Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 64. MacroGenics Revenue Growth Rate in Pediatric Neuroblastoma Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年）

Global Neuroblastoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4085 2021年4月 90Pages
QYResearch社発行の本調査資料では、神経芽細胞腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ...

世界の神経芽細胞腫治療市場 2021：企業別、地域別、種類・用途別

Global Neuroblastoma Treatment Market 2021 by Company, Regions, Type and Application, Forecast to 2026
GIR-2104Z09915 2021年4月 105Pages
当調査資料では、神経芽細胞腫治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。神経芽細胞腫治療の種類別市場規模（併用化学療法、モノクローナル抗体療法、ワクチン療法、その他）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨー...

世界の小児頭蓋骨癒合症治療市場規模・現状・予測（2021年-2027年）

Global Pediatric Craniosynostosis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4483 2021年4月 93Pages
QYResearch社発行の本調査資料では、小児頭蓋骨癒合症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（シングル縫合、ダブル縫合、複雑マルチ縫合）、用途別市場規模（病院、診療所、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロ...

世界の小児放射線学市場規模・現状・予測（2021年-2027年）

Global Pediatric Radiology Market Size, Status and Forecast 2021-2027
QYR2104Z4488 2021年4月 90Pages
QYResearch社発行の本調査資料では、小児放射線学のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（超音波、X線、磁気共鳴画像法、核医学、コンピューター断層撮影）、用途別市場規模（小児超音波、放射線画像、小児X線、小児CTスキャン、小児MR...

世界の小児放射線学市場規模・現状・予測（2021年-2027年）

世界の小児脳腫瘍市場規模・現状・予測（2021年-2027年）

Global Pediatric Brain Tumor Market Size, Status and Forecast 2021-2027
QYR2104Z4481 2021年4月 94Pages
QYResearch社発行の本調査資料では、小児脳腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（神経膠腫、混合神経細胞膠細胞性腫瘍、胚性腫瘍、その他）、用途別市場規模（病院＆診療所、医学研究センター、その他）、主要地域別市場規模（北米、ア...

世界の小児てんかん治療薬市場規模・現状・予測（2021年-2027年）

Global Pediatric Epilepsy Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4484 2021年4月 91Pages
QYResearch社発行の本調査資料では、小児てんかん治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（良性ローランドてんかん、小児欠神てんかん、若年ミオクロニックてんかん、乳児けいれん、レノックス・ガストー症候群）、用途別市場規模（病院...

世界のOTC小児医療市場規模・現状・予測（2021年-2027年）

Global OTC Pediatric Healthcare Market Size, Status and Forecast 2021-2027
QYR2104Z4357 2021年4月 96Pages
QYResearch社発行の本調査資料では、OTC小児医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消化管、皮膚科、ENT、栄養・ビタミン、その他）、用途別市場規模（病院薬局、ドラッグストア/薬局、オンライン薬局）、主要地域別市場規模（北...

世界の小児インターベンション心臓病学市場規模・現状・予測（2021年-2027年）

Global Pediatric Interventional Cardiology Market Size, Status and Forecast 2021-2027
QYR2104Z4486 2021年4月 99Pages
QYResearch社発行の本調査資料では、小児インターベンション心臓病学のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（動脈管開存症、左心房付属器、大動脈弁、肺動脈弁、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米...

世界の小児在宅医療サービス市場規模・現状・予測（2021年-2027年）

Global Pediatric Home Healthcare Services Market Size, Status and Forecast 2021-2027
QYR2104Z4485 2021年4月 125Pages
QYResearch社発行の本調査資料では、小児在宅医療サービスのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（一時的ケア、デイケア、長期的ケア）、用途別市場規模（未熟児、心血管疾患、複合点滴療法、小児腫瘍、慢性疾患、感染症、その他）、主要地域...

世界の神経芽細胞腫治療市場規模・現状・予測（2021年-2027年） Neuroblastoma (NB) is the most common cancer in childhood and infancy. Neuroblastoma is a cancer that starts in primitive nerve cells. It rarely occurs after age around 10 years. Neuroblastoma is sometimes caused by a gene mutation passed from the parent to the child. Market Analysis and Insights: …
世界の神経芽細胞腫治療市場 2021：企業別、地域別、種類・用途別 The Neuroblastoma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
世界の小児頭蓋骨癒合症治療市場規模・現状・予測（2021年-2027年） Craniosynostosis is a condition in which the bones in an infant’s skull grow together too early, causing problems with brain growth and head shape. The edges of the skull bones are called sutures, which normally close by age 2 to 3. With craniosynostosis, the head stops growing in the areas where th…
世界の小児脳腫瘍市場規模・現状・予測（2021年-2027年） Pediatric brain tumors are masses or growths of abnormal cells that occur in a child's brain or the tissue and structures that are near it. Many different types of pediatric brain tumors exist — some are noncancerous (benign) and some are cancerous (malignant). Treatment and chance of recovery (prog…
世界の小児放射線学市場規模・現状・予測（2021年-2027年） Pediatric radiology is a subspecialty of radiology involving the imaging of fetuses, infants, children, adolescents and young adults. The key factor contributing to the pediatric radiology market is the increasing incidence of diagnosis. Market Analysis and Insights: Global Pediatric Radiology Marke…